Public Profile

Shionogi Pharma, Inc.

Shionogi Pharma, Inc., a prominent player in the pharmaceutical industry, is headquartered in the United States and operates extensively across North America. Founded in 1878, Shionogi has established itself as a leader in developing innovative therapies, particularly in the fields of infectious diseases, pain management, and central nervous system disorders. The company is renowned for its unique approach to drug development, focusing on both prescription medications and over-the-counter products that address unmet medical needs. Notable achievements include the successful launch of several key therapies that have significantly improved patient outcomes. With a commitment to research and development, Shionogi Pharma continues to strengthen its market position, contributing to advancements in healthcare and enhancing the quality of life for patients worldwide.

DitchCarbon Score

How does Shionogi Pharma, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

35

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

33

Industry Benchmark

Shionogi Pharma, Inc.'s score of 35 is higher than 66% of the industry. This can give you a sense of how well the company is doing compared to its peers.

66%

Let us know if this data was useful to you

Shionogi Pharma, Inc.'s reported carbon emissions

Shionogi Pharma, Inc., headquartered in the US, currently does not have publicly available carbon emissions data for the most recent year, nor does it specify any reduction targets or initiatives. Without specific emissions figures or commitments, it is challenging to assess their climate impact or sustainability efforts. However, the pharmaceutical industry is increasingly focusing on reducing carbon footprints and enhancing environmental responsibility. As such, Shionogi Pharma may be engaging in industry-standard practices to address climate change, although specific details are not provided.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Shionogi Pharma, Inc.'s primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Shionogi Pharma, Inc. is in US, which has a low grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Shionogi Pharma, Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

ALZA Corporation

US
Pharmaceutical Preparation Manufacturing
Updated 7 days ago

GE Healthcare Limited

GB
Health and social work services (85)
Updated 4 months ago
DitchCarbon Score

Shire plc

IE
Health and social work services (85)
Updated 4 months ago
DitchCarbon Score

NextWave Pharmaceuticals, Inc.

US
Pharmaceutical Preparation Manufacturing
Updated 7 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers